Consumer staples remain a cornerstone of defensive portfolio construction, and both FXG and XLP offer exposure to this resilient segment of the equity market. They do not compete as identical products, however. XLP is a conventional, low-cost index fund capturing the broad large-cap staples complex, while FXG applies a factor-selection screen that deliberately tilts toward smaller and more "value-plus-growth" names within the sector. Comparing them is timely because investors weighing defensive positioning must decide between the efficiency and scale of a market-cap benchmark and the differentiated, but more expensive, factor-driven approach. I also checked this using Tickeron’s AI Screener to see how the two line up on key metrics.
FXG tracks the StrataQuant Consumer Staples AlphaDEX Index, a modified equal-dollar-weighted benchmark that screens constituents from the Russell 1000 Index's consumer staples universe. Its proprietary AlphaDEX methodology ranks stocks on a blend of growth and value factors, then rebalances periodically to emphasize names it identifies as positioned for potential outperformance relative to a traditional passive index. This makes it a passively administered but rules-based, factor-tilted ("smart beta") product.
The fund holds approximately 41 securities, with a top-10 concentration of roughly 40% of assets. Representative top holdings include food, agricultural, and distribution names such as CASY, COKE, PPC, MCK, INGR, SFD, and FRPT. Notably, its exposure extends beyond classic packaged-goods and beverage giants into food distributors, agricultural processors, and healthcare wholesalers. The expense ratio is approximately 0.63%, and the fund carries a mid-cap tilt, with a large portion of assets in companies below mega-cap scale.
XLP seeks to track the Consumer Staples Select Sector Index, which comprises S&P 500 constituents classified under the Global Industry Classification Standard (GICS) as consumer staples. The fund uses a full replication strategy, typically investing at least 95% of assets in the index's securities, and weights holdings by market capitalization.
The portfolio holds roughly 38 names, but it is notably top-heavy: the ten largest positions account for more than 60% of assets. Dominant holdings include WMT, COST, PG, KO, PM, MDLZ, and PEP. The expense ratio is approximately 0.08%, and the fund is one of the largest and most liquid staples ETFs, with assets measured in the tens of billions of dollars. This scale supports exceptionally tight trading spreads and robust daily volume.
Both funds operate within the defensive consumer staples sector, which tends to exhibit lower earnings volatility than cyclical industries. Current conditions favor a nuanced view: persistent inflation in food and household products has pressured volumes for some packaged-goods producers, while grocery and discount retailers have benefited from trade-down behavior. Meanwhile, agricultural processors within FXG's roster face commodity and input-cost sensitivity, adding cyclicality to an otherwise defensive sleeve. Sector flows have favored large, cash-generative mega-caps with pricing power and buyback capacity, a dynamic that structurally advantages XLP's concentration in market leaders. Regulatory scrutiny around food pricing and health-related disclosures remains a modest overhang for the group. From what I see, this backdrop reinforces the importance of cost and liquidity when choosing between the two.
Over recent market cycles, XLP's large-cap, mega-cap-weighted composition has generally provided steadier relative positioning, supported by the scale and pricing power of its top holdings. FXG, by contrast, has exhibited greater dispersion: its mid-cap and agriculture-heavy exposures make its returns more sensitive to commodity prices, freight costs, and idiosyncratic company developments. In environments where investors rotate toward defensive mega-caps, XLP's concentration works in its favor; when mid-cap staples and food names outperform, FXG's factor tilt can deliver differentiated returns but with higher volatility. FXG's elevated expense ratio also represents a persistent drag on long-term relative returns compared with XLP's minimal fee.
I frequently rely on Tickeron’s AI Screener when evaluating ETFs side by side. It lets me filter by industry, market cap, technical patterns, and AI-driven signals to quickly surface how funds like these stack up on liquidity, costs, and risk metrics. The tool helps refine sector research without spending hours on manual analysis, which is especially useful when weighing defensive options in a portfolio. Explore the AI Screener to refine your own ETF and sector research.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for FXG crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 18 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where FXG's RSI Indicator exited the oversold zone, 19 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 55 cases where FXG's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on FXG as a result. In 80 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for FXG just turned positive on October 06, 2026. Looking at past instances where FXG's MACD turned positive, the stock continued to rise in 39 of 47 cases over the following month. The odds of a continued upward trend are 83%.
FXG moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXG advanced for three days, in 258 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 181 of 273 cases where FXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
The 50-day moving average for FXG moved below the 200-day moving average on October 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
FXG broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ConsumerStaples